Popular Children’s Cough Syrup Packaging Determined to be Unsafe

According to the Consumer Products Safety Commission (CPSC) (www.cpsc.gov), two popular children’s cough syrups are being recalled due to the failure of their child-resistant or tamper-proof caps. The two medicines are being recalled immediately because they pose poisoning risks to small children.

The cough syrups, Triaminic and Theraflu are being pulled off the shelves of retailers nationwide, and consumers are urged to take precautions with bottles in their homes. The two brands are sold as Triaminic Syrup and Theraflu Warming Relief Syrup and include 24 different types of the medicines in several flavors and formulations. All recalled products consists of the same failed child-resistant packaging.

Novartis Consumer Health Inc., of Parsippany, NJ, produces the syrups. To date, the company is voluntarily recalling 2.3 million containers of Triaminic and Theraflu Warming Relief syrups.

Child-Resistant Packaging Can Be Opened By Children

Investigation has shown that the child-resistant cap, even with the seal in place, can be opened by small children, and this poses a poisoning risk.

Novartis states that it has received 12 reports of cases in which a child has been able to unscrew the locked cap. Four of the reports state that the children actually ingested the cough syrup, without further incident. However, one of the children required medical attention after consuming an unknown quantity of the syrup.

The Triaminic and Theraflu syrups are packaged in tamper or child-proof containers because the products contain acetaminophen and diphenhydramine. These two substances must be sold in sealed, child-resistant packaging as required by the Poison Prevention Packaging Act.

Recalled Cough Syrup Sold Nationwide

The recalled products include 24 types of Triaminic and Theraflu Warming Relief syrups. They were sold nationwide at many drug stores, grocery stores and club stores between May 2010 and December 2011. They have a retail value of about $5.

The CPSC advises that consumers should take precautions and immediately stop using the product. Consumers who have purchased any of the 24 recalled cough syrups should contact the manufacturer, Novartis, for further information on returning the product for a full refund.